Advanced DMEM/F-12, 10 x 500 mL and 9 more items

Life Technologies Corporation received a contract award (A207_PO-0477686) from the University of Virginia on September 5, 2026, with a cumulative contract value of $3,999.28. The contract encompasses the supply of specialized laboratory materials and biological reagents for neuroscience research applications. Primary product categories include cell culture media (Advanced DMEM/F-12, Neurobasal Medium minus phenol red), supplemental growth factors (GlutaMAX Supplement and B-27 Plus Supplement), laboratory equipment (T80 flasks with tissue culture surface), and recombinant human proteins (CNTF, NT-3, FGF-basic, beta-NGF, and GDNF). All deliverables are designated for delivery to Matthew Scott Yorek at the University of Virginia.

The line items constitute standard consumable and reagent procurement for cellular and tissue culture research. The recombinant protein selections—including nerve growth factor, ciliary neurotrophic factor, and glial cell line-derived neurotrophic factor—indicate research focus on neural development, neuronal survival, and neurodegenerative disease modeling. The contract represents a single purchase order for the specified quantities and unit prices, with no extended performance period identified beyond the award date of September 5, 2026.